Patch Testing Results From the Massachusetts General Hospital Occupational and Contact Dermatitis Clinic, 2017-2022.

IF 4 3区 医学 Q1 DERMATOLOGY
Dermatitis Pub Date : 2023-11-01 Epub Date: 2023-05-24 DOI:10.1089/derm.2023.0085
Hadley Johnson, JiaDe Yu
{"title":"Patch Testing Results From the Massachusetts General Hospital Occupational and Contact Dermatitis Clinic, 2017-2022.","authors":"Hadley Johnson, JiaDe Yu","doi":"10.1089/derm.2023.0085","DOIUrl":null,"url":null,"abstract":"<p><p><u><b><i>Background:</i></b></u> Patch testing is gold standard for identifying the source of allergic contact dermatitis (ACD). <u><b><i>Objective:</i></b></u> To report patch testing results from the Massachusetts General Hospital (MGH) Occupational and Contact Dermatitis Clinic from 2017 to 2022. <u><b><i>Methods:</i></b></u> Retrospective analysis of patients referred to MGH for patch testing, 2017-2022. <u><b><i>Results:</i></b></u> In total, 1438 patients were included. At least 1 positive patch test (PPT) reaction was observed in 1168 (81.2%) patients and at least 1 relevant PPT reaction was observed in 1087 (75.6%) patients. The most common allergen with a PPT was nickel (21.5%), followed by hydroperoxides of linalool (20.4%) and balsam of Peru (11.5%). Sensitization rates statistically increased over time for propylene glycol and decreased for 12 other allergens (all <i>P</i> values <0.0004). <u><b><i>Limitations:</i></b></u> Retrospective design, single institution tertiary referral population, and variations in allergens and suppliers across the study period. <u><b><i>Conclusion:</i></b></u> The field of ACD is constantly evolving. Regular analysis of patch test data is crucial to identify emerging and diminishing contact allergen trends.</p>","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatitis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/derm.2023.0085","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patch testing is gold standard for identifying the source of allergic contact dermatitis (ACD). Objective: To report patch testing results from the Massachusetts General Hospital (MGH) Occupational and Contact Dermatitis Clinic from 2017 to 2022. Methods: Retrospective analysis of patients referred to MGH for patch testing, 2017-2022. Results: In total, 1438 patients were included. At least 1 positive patch test (PPT) reaction was observed in 1168 (81.2%) patients and at least 1 relevant PPT reaction was observed in 1087 (75.6%) patients. The most common allergen with a PPT was nickel (21.5%), followed by hydroperoxides of linalool (20.4%) and balsam of Peru (11.5%). Sensitization rates statistically increased over time for propylene glycol and decreased for 12 other allergens (all P values <0.0004). Limitations: Retrospective design, single institution tertiary referral population, and variations in allergens and suppliers across the study period. Conclusion: The field of ACD is constantly evolving. Regular analysis of patch test data is crucial to identify emerging and diminishing contact allergen trends.

2017-2022年马萨诸塞州总医院职业和接触性皮炎诊所的补丁测试结果。
背景:斑贴试验是鉴别过敏性接触性皮炎(ACD)来源的金标准。目的:报告美国马萨诸塞州总医院(MGH)职业与接触性皮炎门诊2017 - 2022年的斑贴试验结果。方法:回顾性分析2017-2022年在MGH进行贴片试验的患者。结果:共纳入1438例患者。1168例(81.2%)患者出现至少1例阳性斑贴试验(PPT)反应,1087例(75.6%)患者出现至少1例相关PPT反应。最常见的PPT过敏原是镍(21.5%),其次是芳樟醇氢过氧化物(20.4%)和秘鲁香脂(11.5%)。统计上,丙二醇的致敏率随时间增加,而其他12种过敏原的致敏率下降(所有P值限制:回顾性设计,单一机构三级转诊人群,以及整个研究期间过敏原和供应商的变化。)结论:ACD领域在不断发展。定期分析斑贴试验数据对于确定新出现和减少的接触性过敏原趋势至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Dermatitis
Dermatitis 医学-皮肤病学
CiteScore
5.30
自引率
11.50%
发文量
251
审稿时长
>12 weeks
期刊介绍: Dermatitis is owned by the American Contact Dermatitis Society and is the home journal of 4 other organizations, namely Societa Italiana di Dermatologica Allergologica Professionale e Ambientale, Experimental Contact Dermatitis Research Group, International Contact Dermatitis Research Group, and North American Contact Dermatitis Group. Dermatitis focuses on contact, atopic, occupational, and drug dermatitis, and welcomes manuscript submissions in these fields, with emphasis on reviews, studies, reports, and letters. Annual sections include Contact Allergen of the Year and Contact Allergen Alternatives, for which papers are chosen or invited by the respective section editor. Other sections unique to the journal are Pearls & Zebras, Product Allergen Watch, and news, features, or meeting abstracts from participating organizations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信